Advent Pharma (DHA:ADVENT) ROE % Adjusted to Book Value: 0.00% (As of . 20)


DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
29 GF Score
Price BDT16.00
View Full Analysis

What is Advent Pharma ROE % Adjusted to Book Value?

Advent Pharma DHA:ADVENT -0.62% 29 ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 29/100.

Advent Pharma's ROE % for the quarter that ended in . 20 was 0.00%. Advent Pharma's PB Ratio for the quarter that ended in . 20 was N/A. Advent Pharma's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Advent Pharma ROE % Adjusted to Book Value Related Terms

Advent Pharma ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Advent Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma ROE % Adjusted to Book Value Chart

Advent Pharma Annual Data
Trend
ROE % Adjusted to Book Value

Advent Pharma Semi-Annual Data
ROE % Adjusted to Book Value

DHA:ADVENT vs : ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Advent Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advent Pharma ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Advent Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Advent Pharma's ROE % Adjusted to Book Value falls into.


DHA:ADVENT
29GF Score
Advent Pharma Ltd DHA:ADVENT
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advent Pharma ROE % Adjusted to Book Value Calculation

Advent Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Advent Pharma's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Advent Pharma (DHA:ADVENT) has a ROE % Adjusted to Book Value of 0.00% as of . 20. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Advent Pharma and its competitors.
Is Advent Pharma's ROE % Adjusted to Book Value too high?
Advent Pharma's current ROE % Adjusted to Book Value is 0.00%. Overall, Advent Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's ROE % Adjusted to Book Value compare to ?
Advent Pharma's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Advent Pharma and its competitors. Advent Pharma's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Advent Pharma's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
29GF Score

Get the complete analysis for DHA:ADVENT

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT16.00
Price